Jupiteur biotechnology contract R&D for both in-vitro and in-vivo studies include research for the following types of compounds or drug candidates :

• HIV-1 envelope, protease, or reverse transcriptase inhibitors; and vaccine candidates.

• SARS-CoV-2 envelope inhibitors and vaccines candidates.

• Breast cancer cells proliferation inhibitors (here we can also produce cells with specific mutations to mimic the cancer the client plans to study both in-vitro and in-vivo).

• Lung cancer drug candidates (including those involving mutations such as L858R, G719 A/C/S, or T790M)

• Liver, prostate, and skin cancers inhibitors

• Type 2 diabetes drug candidates

• Mycobacterium Tuberculosis inhibitors 

• Drugs targeting the malaria parasite.

• Sanitizers and disinfectants.